|

YJ001 for Spray Use Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.1

Indications

  • Diabetic Peripheral Neuropathic Pain1
  • Diabetes1

Fredericksburg, Texas1 trial

MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Clinical Trials of Texas,LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.